Seroprevalence of antibodies to tick-borne encephalitis virus and Anaplasma phagocytophilum in healthy adults from western Norway

References

• Jore S, Viljugrein H, Hofshagen M, Brun-Hansen H, Kristoffersen A, Nygard K, et al. Multi-source analysis reveals latitudinal and altitudinal shifts in range of Ixodes ricinus at its northern distribution limit. Parasit Vectors 2011;4:84.
   PubMed Web of Science ®Google Scholar
• Blystad H, Vold L, Nygard K. Tick-borne encephalitis in Norway. Epi North 2009; 10: 75–6.
   Google Scholar
• Skarpaas T, Ljostad U, Sundoy A. First human cases of tickborne encephalitis, Norway. Emerg Infect Dis 2004;10: 2241–3.
   PubMed Web of Science ®Google Scholar
• Andreassen A, Jore S, Cuber P, Dudman S, Tengs T, Isaksen K, et al. Prevalence of tick borne encephalitis virus in tick nymphs in relation to climatic factors on the southern coast of Norway. Parasit Vectors 2012;5:177.
   PubMed Web of Science ®Google Scholar
• Ytrehus B, Vainio K, Dudman SG, Gilray J, Willoughby K. Tick-Borne Encephalitis Virus and Louping-Ill Virus May Co-Circulate in Southern Norway. Vector Borne Zoonotic Dis 2013;13:762–8.
   PubMed Web of Science ®Google Scholar
• Traavik T. Serological investigations indicating the existence of tick-borne encephalitis virus foci along the Norwegian coast. Acta Pathol Microbiol Scand B 1973;81: 138–42.
   Google Scholar
• Traavik T. Antibodies to tick-borne encephalitis virus in human sera from the western coast of Norway. Acta Pathol Microbiol Scand B 1979;87B:9–13.
   PubMedGoogle Scholar
• Traavik T, Mehl R, Wiger R. The first tick-borne encephalitis virus isolates from Norway. Acta Pathol Microbiol Scand B 1978;86:253–5.
   PubMedGoogle Scholar
• Gao GF, Jiang WR, Hussain MH, Venugopal K, Gritsun TS, Reid HW, et al. Sequencing and antigenic studies of a Norwegian virus isolated from encephalomyelitic sheep confirm the existence of louping ill virus outside Great Britain and Ireland. J Gen Virol 1993;74:109–14.
   PubMed Web of Science ®Google Scholar
• Haglund M. Occurrence of TBE in areas previously considered being non-endemic: Scandinavian data generate an international study by the International Scientific Working Group for TBE (ISW-TBE). Int J Med Microbiol 2002;291 Suppl 33: 50–4.
   PubMed Web of Science ®Google Scholar
• Stuen S, Bergstrom K. [Human anaplasmosis—a hidden disease in Norway?]. Tidsskr Nor Laegeforen 2008;128: 2579–81.
   PubMedGoogle Scholar
• Bakken JS. The discovery of human granulocytotropic ehrlichiosis. J Lab Clin Med 1998;132:175–80.
   PubMed Web of Science ®Google Scholar
• Strle F. Human granulocytic ehrlichiosis in Europe. Int J Med Microbiol 2004;293 Suppl 37:27–35.
   PubMed Web of Science ®Google Scholar
• Kristiansen BE, Jenkins A, Tveten Y, Karsten B, Line O, Bjoersdorff A. [Human granulocytic ehrlichiosis in Norway]. Tidsskr Nor Laegeforen 2001;121:805–6.
   PubMedGoogle Scholar
• Bakken JS, Krueth J, Tilden RL, Dumler JS, Kristiansen BE. Serological evidence of human granulocytic ehrlichiosis in Norway. Eur J Clin Microbiol Infect Dis 1996;15:829–32.
   PubMed Web of Science ®Google Scholar
• Mysterud A, Easterday WR, Qviller L, Viljugrein H, Ytrehus B. Spatial and seasonal variation in the prevalence of Anaplasma phagocytophilum and Borrelia burgdorferi sensu lato in questing Ixodes ricinus ticks in Norway. Parasit Vectors 2013;6:187.
   PubMed Web of Science ®Google Scholar
• Rosef O, Radzijevskaja J, Paulauskas A, Haslekas C. The prevalence of Anaplasma phagocytophilum in host-seeking Ixodes ricinus ticks in Norway. Clin Microbiol Infect 2009;15 Suppl 2: 43–5.
   PubMed Web of Science ®Google Scholar
• Hjetland R, Eliassen KE, Lindbaek M, Nilsen RM, Grude N, Ulvestad E. Tick bites in healthy adults from western Norway: Occurrence, risk factors, and outcomes. Ticks Tick Borne Dis 2013;4:304–10.
   PubMed Web of Science ®Google Scholar
• Hjetland R, Nilsen RM, Grude N, Ulvestad E. Seroprevalence of antibodies to Borrelia burgdorferi sensu lato in healthy adults from western Norway: Risk factors and methodological aspects. APMIS 2014;122:1114–24. Available from: URL: http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1600-0463/earlyview
   PubMed Web of Science ®Google Scholar
• Vene S, Haglund M, Vapalahti O, Lundkvist A. A rapid fluorescent focus inhibition test for detection of neutralizing antibodies to tick-borne encephalitis virus. J Virol Methods 1998;73:71–5.
   PubMed Web of Science ®Google Scholar
• Skarpaas T, Sundoy A, Bruu AL, Vene S, Pedersen J, Eng PG, et al. [Tick-borne encephalitis in Norway]. Tidsskr Nor Laegeforen 2002;122:30–2.
   PubMedGoogle Scholar
• Larsen AL, Kanestrom A, Bjorland M, Andreassen A, Soleng A, Vene S, et al. Detection of specific IgG antibodies in blood donors and tick-borne encephalitis virus in ticks within a non-endemic area in southeast Norway. Scand J Infect Dis 2014;46:181–4.
   PubMed Web of Science ®Google Scholar
• Gustafson R. Epidemiological studies of Lyme borreliosis and tick-borne encephalitis. Scand J Infect Dis Suppl 1994;92:1–63.
   PubMedGoogle Scholar
• Aguero-Rosenfeld ME, Donnarumma L, Zentmaier L, Jacob J, Frey M, Noto R, et al. Seroprevalence of antibodies that react with Anaplasma phagocytophila, the agent of human granulocytic ehrlichiosis, in different populations in Westchester County, New York. J Clin Microbiol 2002;40: 2612–5.
   PubMed Web of Science ®Google Scholar
• Walder G, Tiwald G, Dierich MP, Wurzner R. Serological evidence for human granulocytic ehrlichiosis in Western Austria. Eur J Clin Microbiol Infect Dis 2003;22:543–7.
   PubMed Web of Science ®Google Scholar
• Dumler JS, Madigan JE, Pusterla N, Bakken JS. Ehrlichioses in humans: epidemiology, clinical presentation, diagnosis, and treatment. Clin Infect Dis 2007;45 Suppl 1:S45–51.
   PubMedGoogle Scholar
• Leiby DA, Chung AP, Cable RG, Trouern-Trend J, McCullough J, Homer MJ, et al. Relationship between tick bites and the seroprevalence of Babesia microti and Anaplasma phagocytophila (previously Ehrlichia sp.) in blood donors. Transfusion 2002;42:1585–91.
   PubMed Web of Science ®Google Scholar
• Skarphedinsson S, Sogaard P, Pedersen C. Seroprevalence of human granulocytic ehrlichiosis in high-risk groups in Denmark. Scand J Infect Dis 2001;33:206–10.
   PubMedGoogle Scholar
• Dumler JS, Dotevall L, Gustafson R, Granstrom M. A population-based seroepidemiologic study of human granulocytic ehrlichiosis and Lyme borreliosis on the west coast of Sweden. J Infect Dis 1997;175:720–2.
   PubMed Web of Science ®Google Scholar
• Wittesjo B, Bjoersdorff A, Eliasson I, Berglund J. First long-term study of the seroresponse to the agent of human granulocytic ehrlichiosis among residents of a tick-endemic area of Sweden. Eur J Clin Microbiol Infect Dis 2001;20: 173–8.
   PubMed Web of Science ®Google Scholar